J. Brian Byrd
Internal Medicine - Cardiology
MD, Medical University of South Carolina
MS, Clinical Investigation, Vanderbilt University
Recently, his laboratory has published novel assays to detect mineralocorticoid receptor-regulated gene expression in cell-depleted human urine. The ability to detect these signals in human urine opens promising new avenues of investigation toward clinically useful biomarkers of human mineralocorticoid receptor activation.
He is a principal investigator at the University of Michigan School of Medicine, where he is Assistant Professor in the Department of Internal Medicine’s Division of Cardiovascular Medicine. He has received several awards for his academic work, including the NIH K23 Award, and the Central Society of Clinical and Translational Research Early Career Development Award. In addition, he is a co-investigator on the MIPACT study of health trajectories, helping to guide blood pressure-related aspects of that study.
Novel transcriptional biomarker of mineralocorticoid receptor activation
MIPACT | Rogel Cancer Center
Biomarkers | Clinical research | cardiovascular diseases
- Anxiety in the “Age of Hypertension”
- Cigarette smoking and subtypes of uncontrolled blood pressure among diagnosed hypertensive patients: Paradoxical associations and implications
- Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism
- Principal investigator of: Peripheral Blood Transcriptional Biomarkers of Mineralocorticoid Receptor Activation
- Principal investigator of: A Novel Biomarker of Mineralocorticoid Receptor Activation
- Co-investigator of: Michigan Predictive Activity & Clinical Trajectories (MIPACT) Study